Dermatol. praxi. 2018;12(4):167-170 | DOI: 10.36290/der.2018.029

Topical treatment of psoriasis

MUDr. Zuzana Baranová, PhD.
Klinika dermatovenerológie LF UPJŠ a UNLP, Košice

This article presents an overview of options for topical treating psoriasis. Although a wide range of topical and systemictreatments are available, no psoriasis treatment is universally effective. Treatment depends on the location of lesions, theirsize, the amount of the skin affected, previous response to treatment, and preferences for treatment. Topical therapiesinclude moisturizer, keratolytic agents, coal tar, anthralin, topical corticosteroids, topical vitamin D3, tazarotene. Patientswith middle to moderate psoriasis are treated initially with topical treatments, Topical treatments are often inexpensive andefficacious and have a very good safety profile. Most psoriatic patients cannot sustain a treatment-free remission. Managementis needed to decrease of an exacerbation of psoriasis and to improve the quality of the life of the psoriasis patient.Combinations of therapies may be used to maximize benefit and reduce side effects. Dermatologists must individualize atreatment regimen to psoriatic patient.

Keywords: psoriasis, topical treatment, phototherapy

Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Baranová Z. Topical treatment of psoriasis. Dermatol. praxi. 2018;12(4):167-170. doi: 10.36290/der.2018.029.
Download citation

References

  1. Kragballe K. Topical therapy of psoriasis. In: Sterry W, Sabat R, et al. Psoriasis: diagnosis and management. John Wiley & Sons, Ltd; 2015: 289-175.
  2. Lebwohl MG, van de Kerkhof P. Psoriasis. In: Lebwohl MG, et al. Treatment of Skin Disease. Elsevier Limited; 2018: 2326-2362. Go to original source...
  3. Mitra A, Atillasoy E. Topical Therapies for Psoriasis. In: Soung J, Koo B. Psoriasis. InTech; 2012: 309-330 Go to original source...
  4. Kamili Q, Menter A. Topical Treatment of Psoriasis In: Yawalkar N, (ed). Management of Psoriasis. Basel: Karger; 2009: 37-58. Go to original source... Go to PubMed...
  5. Hawkes JE, Duffin KC. Topical and Systemic Therapies for Moderate-to-Severe Psoriasis. In: Adebajo A, et al. Psoriatic Arthritis and Psoriasis Pathology and Clinical Aspects. Springer; 2016: 253-266 Go to original source...
  6. Ma Ch, Maverakis E. Current Recommendations for the Treatment of Psoriasis. In: Rachaudhuri P, et al. Psoriasis and psoriatic arthritis. CRC Press/Taylor & Francis Group; 2018: 177-193. Go to original source...
  7. Lebwohl M. The role of salicylic acid in the treatment of psoriasis. Int J Dermatol. 1999; 38: 16-24. Go to original source...
  8. Gupta R., Debbaneh M, Butler D, et al. The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis. J Vis Exp. 2013; 77: 505-509. Go to original source...
  9. Jayakar T, Parimalam K. Dermatological Indications and Usage of Topical Corticosteroid. In: Lahiri K. A Treatise on Topical Corticosteroids in Dermatology. Springer. 2018; 23-40. Go to original source...
  10. Leyssens C, Verlinden L, Verstuyf A. The future of vitamin D analogs. Front Physiol. 2014; 5: 122-139. Go to original source... Go to PubMed...
  11. Barrea L, Savanelli MC, et al. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev Endocr Metab Disord. 2017; 18: 195-205. Go to original source... Go to PubMed...
  12. Rafael A, Torres T. Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors. Eur J Dermatol. 2016: 26(1): 3-8. Go to original source...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.